http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009019188-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfe1ad3b27a506e4dcede75d5db6cb1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_003fa00b2da60d6d52ceba7217f03560 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35263a5e3bfd9f155ac5c61e08a7db97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddcb273a108a5d8472b335280098e06 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef39c37d4edfac61514518c7849bafbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_993b236b1bb99636f326c988bea9c837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e47132819ac4b39fde1260debdf0d28 |
| publicationDate | 2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009019188-A1 |
| titleOfInvention | Diagnostic substance for use in a method for determining the aggressiveness of a prostate tumor and diagnostic method |
| abstract | The invention relates to a diagnostic substance for use in a method for determining the aggressiveness of a prostate tumor and to a corresponding method. The diagnostic substance comprises a biomarker, which is provided with a first label detectable by a detection device and binds specifically to a VEGF molecule. In the method, a diagnostic agent is introduced to the prostate via the bloodstream, said agent comprising a biomarker and a first label connected thereto and detectable by a detection device, a biomarker being used that binds specifically to a VEGF molecule of the vascular endothelium. Using the extracorporeally or intracorporeally positioned detection device, a signal is generated, the strength of which proportional to the number or density of VEGF molecules present in a tissue region. Biomarkers binding to the CD34 molecule or to ICAM-1 can also be used. |
| priorityDate | 2007-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.